CD19-CAR novel oncolytic vaccinia virus (Second Affiliated Hospital School Of Zhejiang University School Of Medicine)

N/A

Report date: 2026/02/11 20:01:36

Base Information

Drug NameCD19-CAR novel oncolytic vaccinia virus (Second Affiliated Hospital School Of Zhejiang University School Of Medicine)
Drug Alias NameRGV005RGV-005
ClassificationBiologics > Oncolytic virus
Mechanisms of ActionB-lymphocyte antigen CD19 modulators
TargetsB-lymphocyte antigen CD19
Therapy Area/IndicationsLymphoma, B-Cell
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesSecond Affiliated Hospital School Of Zhejiang University School Of Medicine
China Registration ClassN/A

Develop Information

Active CompaniesSecond Affiliated Hospital School Of Zhejiang University School Of Medicine
Inactive CompaniesN/A
Active IndicationsLymphoma, B-Cell
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A